[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336966-105":59,"doc-detail-336966-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","phosphoribosyl-pyrophosphate-amidotransferase-novel-biomarker-and-therapeutic-target-for-nasopharyngeal-carcinoma","Phosphoribosyl pyrophosphate amidotransferase - Novel biomarker and therapeutic target for nasopharyngeal carcinoma","","Cancer cells rely on a high and dynamic demand for nucleotides to support proliferation, making de novo purine biosynthesis a critical dependency. The enzyme phosphoribosyl pyrophosphate amidotransferase (PPAT), which catalyzes the first step of de novo purine biosynthesis, is strongly expressed in multiple cancers. This study demonstrates increased PPAT expression in nasopharyngeal carcinoma (NPC), including EBV-positive cases, and shows that PPAT knockdown reduces NPC proliferation and invasion. PPAT induction is driven by glutamine, and blocking glutamine-mediated PPAT expression suppresses tumor cell growth. In human tissues, PPAT increases with disease progression and correlates with poor prognosis, supporting PPAT as a prognostic biomarker and therapeutic target for aggressive NPC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phosphoribosyl-pyrophosphate-amidotransferase-novel-biomarker-and-therapeutic-target-for-nasopharyngeal-carcinoma/336966/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phosphoribosyl-pyrophosphate-amidotransferase-novel-biomarker-and-therapeutic-target-for-nasopharyngeal-carcinoma/336966.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PPAT and why is it important for NPC?","Question",{"text":112,"@type":113},"PPAT catalyzes the first step of de novo purine biosynthesis, a pathway cancer cells depend on for nucleotide supply. The study reports that PPAT is upregulated in nasopharyngeal carcinoma, supporting its role in tumor growth and invasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is PPAT expression regulated in NPC cells?",{"text":117,"@type":113},"PPAT is regulated by glutamine, which acts as a cosubstrate for PPAT. A glutamine antagonist blocks glutamine-mediated induction of PPAT and reduces NPC cell proliferation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PPAT relate to patient prognosis and disease progression?",{"text":121,"@type":113},"Immunohistochemical analysis shows increased PPAT expression in NPC tissues with disease progression. Higher PPAT levels are significantly associated with poor prognosis, indicating PPAT as a potential prognostic biomarker for aggressive NPC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336966,1790176687,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","DOI: 10. 1111/cas.16314  \nOR I G I NAL ART I C L E  \nPhosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma  \nYuki Kitagawa1  | Satoru Kondo1  | Masaki Fukuyo2 | Kousho Wakae3 | Hirotomo Dochi1  | Harue Mizokami1 | Shigetaka Komura1 | Eiji Kobayashi1 | Nobuyuki Hirai1 | Takayoshi Ueno1 | Yosuke Nakanishi1 | Kazuhira Endo1 | Hisashi Sugimoto1 | Naohiro Wakisaka1 | Atsushi Kaneda2  | Tomokazu Yoshizaki1  \n1Division of Otolaryngology and Head and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan  \n2Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan 3 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan  \nCorrespondence  \nSatoru Kondo, Division of OtolaryngologyHead and Neck Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan.  \nEmail: [ksatoru@med.kanazawa-u.ac.jp](ksatoru@med.kanazawa-u.ac.jp)  \nAbstract  \nCancer cells show a dynamic metabolic landscape, requiring a sufficient supply of nucleotides to proliferate. They are highly dependent on de novo purine biosynthetic pathways for their nucleotide requirements. Phosphoribosyl pyrophosphate amidotransferase (PPAT), catalyzing the first step of de novo purine biosynthesis, is highly expressed in various cancers. We observed an increased expression of PPAT in nasopharyngeal carcinoma (NPC) . Moreover, our ribonucleic acid sequencing analysis showed high PPAT expression in Epstein–Barr virus-positive NPC, which was supported by in vitro analysis. Through a gene knockdown study, we showed that the suppression of PPAT expression reduced the proliferation and invasion of NPC cells. We also demonstrated the regulation of PPAT by glutamine, a cosubstrate for PPAT. A glutamine antagonist, 6-diazo-5-oxo-L-norleucine, blocked glutamine-mediated induction of PPAT and reduced NPC cell proliferation. Immunohistochemical analysis of PPAT in NPC tissues revealed increased expression of PPAT with disease progression, which was significantly associated with poor prognosis. In summary, this study highlighted the biological function of PPAT in NPC, establishing its potential as a novel prognostic biomarker for aggressive NPC and a promising therapeutic target.  \nK E Y WO R D S  \nEpstein–Barr virus, glutamine, nasopharyngeal carcinoma, PPAT, purine biosynthesis  \nAbbreviations: DON, 6-diazo-5-oxo-L-norleucine; EBER, EBV-encoded small RNA; EBNA1, Epstein-Barr nuclear antigen 1; EBV, Epstein–Barr virus; eGFP, enhanced GFP; JCRB, Japanese Collection of Research Biosources; LMP, latent membrane protein; neor, neomycin-resistant; NPC, nasopharyngeal carcinoma; PPAT, phosphoribosyl pyrophosphate amidotransferase; qRT-PCR, quantitative real-time PCR; RNA-seq, RNA sequencing.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2024 The Author(s) . Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.  \n1 | INTRODUCTION  \nNasopharyngeal carcinoma is a unique cancer in which EBV is implicated in carcinogenesis.1–3 Epstein–Barr virus establishes a latent infection characterized by the expression of a limited subset of viral genes known as latent genes, such as EBV nuclear antigens, latent membrane proteins, and small RNAs. We have previously reported that LMP1 activates multiple cellular signaling pathways, eventually developing NPC.1,4–6 Although the prognosis of patients with NPC has improved due to recent advances in radiation therapy and chemotherapy, some NPC cohorts still show poor prognosis with a high potential for metastasis. Therefore, an indepth exploration of effective targets for NPC treatment is necessary to improve patient ou","cbCaie6i1XKlKeur","https://ap.wps.com/l/cbCaie6i1XKlKeur","pdf",3513121,"English","# Introduction\n# Materials and Methods\n## Patient samples","[{\"question\":\"What is PPAT and why is it important for NPC?\",\"answer\":\"PPAT catalyzes the first step of de novo purine biosynthesis, a pathway cancer cells depend on for nucleotide supply. The study reports that PPAT is upregulated in nasopharyngeal carcinoma, supporting its role in tumor growth and invasion.\"},{\"question\":\"How is PPAT expression regulated in NPC cells?\",\"answer\":\"PPAT is regulated by glutamine, which acts as a cosubstrate for PPAT. A glutamine antagonist blocks glutamine-mediated induction of PPAT and reduces NPC cell proliferation.\"},{\"question\":\"How does PPAT relate to patient prognosis and disease progression?\",\"answer\":\"Immunohistochemical analysis shows increased PPAT expression in NPC tissues with disease progression. Higher PPAT levels are significantly associated with poor prognosis, indicating PPAT as a potential prognostic biomarker for aggressive NPC.\"}]","Phosphoribosyl pyrophosphate amidotransferase - Novel biomarker and therapeutic target for nasopharyngeal carcinoma | PDF",1790017229,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b8311fa311b1dfa2b1ad46fa38d70c7.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39a0b32339151fbf0486d403cf52b555.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae7f81f44e68a42f02d0086fc872fd74.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2217c6f2bdb8753a623ff2ecae0deb4e.webp",980,1287]